Transforming growth factor beta 1 (TGFβ1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients

Cytokine

Volumn 45, Issue 3, 2009, Pages 149-153

  Calzada, Jose E ^a   Beraún, Yasmina ^b   González, Clara I ^c   Martín, Javier ^b  

^a Instituto Conmemorativo Gorgas de Estudios de la Salud   (Panama)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Chagas disease; Polymorphism; Transforming growth factor; Trypanosoma cruzi

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALLELE; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CODON; COLOMBIA; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PERU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AMERICA; TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; AGED; CHAGAS DISEASE; COHORT STUDIES; COLOMBIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PERU; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1;

TRYPANOSOMA CRUZI;

EID: 60649121513     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.11.013     Document Type: Article

References (31)

1. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1 2 (2001) 92-100
2. Zicker F., Smith P.G., Netto J.C., Oliveira R.M., and Zicker E.M. Physical activity, opportunity for reinfection, and sibling history of Heart disease as a risk factor for Chagas disease cardiopathy. Am J Trop Med Hyg 43 5 (1990) 498-505
3. Williams-Blangero S., Vandeberg J.L., Blangero J., and Teixera A.R.L. Genetic epidemiology of seropositivity for Trypanosoma cruzi infection in rural Goias, Brazil. Am J Trop Med Hyg 57 5 (1997) 538-543
4. Reed S.G. TGF-beta in infections and infectious diseases. Microbes Infect 15 1 (1999) 1313-1325
5. Martin D.L., Postan M., Lucas P., Gress R., and Tarleton R.L. TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection. Eur J Immunol 37 10 (2007) 2764-2771
6. Waghabi M.C., Keramidas M., Calvet C.M., Meuser M., de Nazaré C., Soeiro M., et al. SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion. Antimicrob Agents Chemother 51 8 (2007) 2905-2910
7. Araujo-Jorge T.C., Waghabi M.C., Hasslocher-Moreno A.M., Xavier S.S., Higuchi Mde L., Keramidas M.J.J., et al. Implication of transforming growth factor-beta 1 in Chagas disease myocardiopathy. J Infect Dis 186 12 (2002) 1823-1828
8. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., and Hutchinson I.V. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 8 (1998) 1014-1020
9. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet 8 1 (1999) 93-97
10. Shah R., Hurley C.K., and Posch P.E. A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C > T). Hum Genet 120 4 (2006) 461-469
11. Lympany P.A., Avila J.J., Mullighan C., Marshall S., Welsh K.I., and du Bois R.M. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 52 6 (1998) 573-578
12. Colorado I.A., Acquatella H., Catalioti F., Fernandez M.T., and Layrisse Z. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol 61 3 (2000) 320-325
13. Nieto A., Beraún Y., Collado M.D., Caballero A., Alonso A., González A., et al. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 55 3 (2000) 195-198
14. Calzada J.E., Nieto A., Beraún Y., and Martín J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 58 3 (2001) 154-158
15. Rodríguez-Pérez J.M., Cruz-Robles D., Hernández-Pacheco G., Pérez-Hernández N., Murguía L.E., Granados J., et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 98 1 (2005) 97-102
16. Zafra G., Morillo C., Martín J., González A., and González C.I. Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 9 9 (2007) 1049-1052
17. Beraún Y., Nieto A., Collado M.D., González A., and Martín J. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 52 1 (1998) 81-83
18. Drigo S.A., Cunha-Neto E., Ianni B., Mady C., Faé K.C., Buck P., et al. Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett 108 1 (2007) 109-111
19. Ming M., Ewen M.E., and Pereira M.E. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell 82 2 (1995) 287-296
20. Fitzpatrick D.R., and Bielefeldt-Ohmann H. Transforming growth factor beta in infectious disease: always there for the host and the pathogen. Trends Microbiol 7 6 (1999) 232-236
21. Hall B.S., and Pereira M.A. Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect Immun 68 4 (2000) 2077-2081
22. Silva J.S., Twardzik D.R., and Reed S.G. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J Exp Med 174 3 (1991) 539-545
23. Damatta R.A., Seabra S.H., Deolindo P., Arnholdt A.C., Manhães L., Goldenberg S., et al. Trypanosoma cruzi exposes phosphatidylserine as an evasion mechanism. FEMS Microbiol Lett 266 1 (2007) 29-33
24. Rafiei A., Hajilooi M., Shakib R.J., and Alavi S.A. Transforming growth factor-beta1 polymorphisms in patients with brucellosis: an association between codon 10 and 25 polymorphisms and brucellosis. Clin Microbiol Infect 13 1 (2007) 97-100
25. Mak J.C., Leung C.M., Sham A.S., Mok T.Y., Poon Y.N., Ling S.O., et al. Genetic polymorphisms and plasma levels of transforming growth factor-β1 in Chinese patients with tuberculosis in Hong Kong. Cytokine 40 3 (2007) 177-182
26. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 24 (2000) 2783-2787
27. Yamada Y., Fujisawa M., Ando F., Niino N., Tanaka M., and Shimokata H. Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals. J Hum Genet 47 5 (2002) 243-248
28. de Pablo R., Beraún Y., Nieto A., Calzada J.E., Rementería M.C., Sanz L., López-Nevot M.A., and Martín J. HLA class I and class II allele distribution in the Peruvian population. Tissue Antigens 56 6 (2000) 507-514
29. Rothhammer F., Allison M., Nuñez L., Standen V., and Arriaza B. Chagaś disease in pre-Columbian South America. Am J Phy Anthropol 68 4 (1985) 495-498
30. Klein J., Satta Y., O'hUigin C., and Takahata N. The molecular descent of the major histocompatibility complex. Annu Rev Immunol 11 (1993) 269-295
31. Hill A.V. The immunogenetics of human infectious diseases. Annu Rev Immunol 16 (1998) 593-617